ADS

Adocia reports positive preliminary results for first clinical trial of BioChaperone Combo

By

February 27, 2014
Spread the love

Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia’s BioChaperone technology. …read more    

By